By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.
It’s in line with President Donald Trump’s executive order in May to shift manufacturing of drugs to the US Read more at The Business Times.
Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...
The Print on MSN
Cheaper cancer, diabetes drugs: Rs 10,000 cr ‘Biopharma Shakti’ to power India’s biologics push
Centre unveil 5-yr Rs 10,000 cr programme to boost domestic biologics & biosimilars, aiming to cut costs import dependence.
Pfizer has fallen behind the pack when it comes to GLP-1 drugs, but the company is still fighting.
The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, ...
Nirmala Sitharaman presented the Union Budget 2026-27, outlining a comprehensive strategy to strengthen India's manufacturing ...
The Union Budget 2026–27 launches a major biopharma initiative to boost domestic production of biologics and biosimilars, aiming to reduce imports and strengthen healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results